Mepolizumab (Synonyms: SB 240563) |
| Katalog-Nr.GC66347 |
Mepolizumab (SB 240563) ist ein humanisierter monoklonaler AntikÖrper, der an Interleukin-5 (IL-5), das wichtigste Zytokin, das an der Proliferation, Aktivierung und dem Überleben von Eosinophilen beteiligt ist, bindet und es neutralisiert. Mepolizumab kann zur Erforschung der eosinophilen Granulomatose mit Polyangiitis (EGPA) und des schweren eosinophilen Asthmas eingesetzt werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 196078-29-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma[1][2].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *